AXP
69
2
ADM
30
2
DVN
25
4
SWN
82
2
GIS
49
6
EOG
47
9
NAVI
40
4
VRSN
60
3
SO
64
4
EQR
48
-2
V
42
4
ZBH
53
-3
TAP
53
5
UHS
59
-8
PRGO
39
2
HUM
34
-7
QRVO
47
-5
HIG
70
2
USB
51
-2
OKE
67
2
AXP
69
2
ADM
30
2
DVN
25
4
SWN
82
2
GIS
49
6
EOG
47
9
NAVI
40
4
VRSN
60
3
SO
64
4
EQR
48
-2
V
42
4
ZBH
53
-3
TAP
53
5
UHS
59
-8
PRGO
39
2
HUM
34
-7
QRVO
47
-5
HIG
70
2
USB
51
-2
OKE
67
2
Financhill
Back

FibroGen Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
25

FGEN
FibroGen

Last Price:
0.40
Seasonality Move:
5.66%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
25
FibroGen (FGEN) is a Sell

Is FibroGen a Buy, Sell or Hold?

  • The current FibroGen [FGEN] share price is $0.41. The Score for FGEN is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • FGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FGEN Stock Price Chart

What is FibroGen's stock price today?

  • The FibroGen share price today is $0.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

FGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 45.32 Sell
Chaikin Money Flow: 215571 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.37 - 0.43) Buy
Bollinger Bands (100): (0.44 - 1.18) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

FGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.4 Buy
20-day SMA: 0.4 Buy
50-day SMA: 0.53 Sell
200-day SMA: 1.15 Sell
8-day EMA: 0.4 Buy
20-day EMA: 0.41 Sell
50-day EMA: 0.54 Sell
200-day EMA: 1.64 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

FibroGen Earnings Growth & FGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.29 per share, an increase this year of $1.44 per share, and an increase next year of $0.65 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

FibroGen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):